UF Research Foundation Names 2024 Professors
The University of Florida Research Foundation has named 34 of the university’s most productive and promising faculty members as UFRF Professors for 2024.
OncoMyx Announces Exclusive Option to License Intellectual Property Rights for Myxoma Virus Technology from University of Florida
OncoMyx Therapeutics, a privately-held oncolytic immunotherapy company, has extended its intellectual property (IP) portfolio to include an exclusive option to license IP rights for the use and delivery of myxoma virus to treat certain cancers from the University of Florida Research Foundation (UFRF).
TheraVab Biosciences Announces Exclusive Option to License Engineered Receptor Immunobiotherapy for the Treatment of Neu
TheraVab Biomedics Pte. Ltd., a pre-clinical stage immunotherapy company that aims at reversal of the inflammatory processes that lead to cancers, neurodegenerative... Read More
Local UF Professor Garners Third Professorship Award
Zhenli He, Ph.D., received a 2020 University of Florida Research Foundation Professorship Award, a term that will continue through 2023. The award... Read More
UF Ranked No. 1 Nationally in Innovation Impact
The University of Florida is the most productive large university in the country at leveraging its research funding into new companies, new... Read More
Top 100 Worldwide Universities Granted U.S. Utility Patents in 2019 Announced
The Top 100 Worldwide Universities Granted U.S. Utility Patents in 2019 report was released by the National Academy of Inventors (NAI) and the... Read More
Mishra Named a UF Research Foundation Professor
The University of Florida Research Foundation (UFRF) has named Prabhat Mishra, Ph.D., a professor in the Department of Computer & Information Science &... Read More
